Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB.

N Engl J Med. 2006 Jan 26;354(4):424-5. No abstract available.

PMID:
16436782
[PubMed - indexed for MEDLINE]
Free Article
2.

The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Thaler A, Ash E, Gan-Or Z, Orr-Urtreger A, Giladi N.

J Neural Transm. 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0. Review.

PMID:
19756366
[PubMed - indexed for MEDLINE]
3.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N.

Neurology. 2007 Oct 16;69(16):1595-602.

PMID:
17938369
[PubMed - indexed for MEDLINE]
4.

Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.

Bar-Shira A, Hutter CM, Giladi N, Zabetian CP, Orr-Urtreger A.

Neurogenetics. 2009 Oct;10(4):355-8. doi: 10.1007/s10048-009-0186-0. Epub 2009 Mar 13.

PMID:
19283415
[PubMed - indexed for MEDLINE]
5.

LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.

Lesage S, Dürr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A; French Parkinson's Disease Genetics Study Group.

N Engl J Med. 2006 Jan 26;354(4):422-3. No abstract available.

PMID:
16436781
[PubMed - indexed for MEDLINE]
Free Article
6.

Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.

Eblan MJ, Scholz S, Stubblefield B, Gutti U, Goker-Alpan O, Hruska KS, Singleton AB, Sidransky E.

Neurosci Lett. 2006 Aug 14;404(1-2):163-5. Epub 2006 Jun 15.

PMID:
16781064
[PubMed - indexed for MEDLINE]
7.

The G2019S LRRK2 mutation: another morbid burden for Ashkenazi Jews may provide new insights on sporadic Parkinson's disease.

Melamed E.

Mov Disord. 2013 Dec;28(14):1912-4. doi: 10.1002/mds.25728. Epub 2013 Dec 4. No abstract available.

PMID:
24307480
[PubMed - indexed for MEDLINE]
8.

High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain).

Sierra M, González-Aramburu I, Sánchez-Juan P, Sánchez-Quintana C, Polo JM, Berciano J, Combarros O, Infante J.

Mov Disord. 2011 Nov;26(13):2343-6. doi: 10.1002/mds.23965. Epub 2011 Sep 27.

PMID:
21954089
[PubMed - indexed for MEDLINE]
9.

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Neurology. 2006 Nov 28;67(10):1786-91. Epub 2006 Oct 18.

PMID:
17050822
[PubMed - indexed for MEDLINE]
10.

Clinical characteristics of Parkinson's disease among Jewish Ethnic groups in Israel.

Djaldetti R, Hassin-Baer S, Farrer MJ, Vilariño-Güell C, Ross OA, Kolianov V, Yust-Katz S, Treves TA, Barhum Y, Hulihan M, Melamed E.

J Neural Transm. 2008 Sep;115(9):1279-84. doi: 10.1007/s00702-008-0074-z. Epub 2008 Jul 30.

PMID:
18665323
[PubMed - indexed for MEDLINE]
11.

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.

Hassin-Baer S, Laitman Y, Azizi E, Molchadski I, Galore-Haskel G, Barak F, Cohen OS, Friedman E.

J Neurol. 2009 Mar;256(3):483-7. doi: 10.1007/s00415-009-0117-x. Epub 2009 Mar 24.

PMID:
19412725
[PubMed - indexed for MEDLINE]
12.

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.

Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, Nitsan Z, Ephraty L, Tunkel O, Kozlova E, Inzelberg L, Kaplan N, Fixler Mehr T, Mory A, Dagan E, Schechtman E, Friedman E, Hassin-Baer S.

Neurology. 2012 Mar 13;78(11):781-6. doi: 10.1212/WNL.0b013e318249f673. Epub 2012 Feb 8.

PMID:
22323743
[PubMed - indexed for MEDLINE]
13.

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.

Nichols WC, Pankratz N, Hernandez D, Paisán-Ruíz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T; Parkinson Study Group-PROGENI investigators.

Lancet. 2005 Jan 29-Feb 4;365(9457):410-2.

PMID:
15680455
[PubMed - indexed for MEDLINE]
14.

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.

Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T, Bar-Shira A, Orr-Urtreger A.

Neurology. 2008 Jun 10;70(24):2277-83. doi: 10.1212/01.wnl.0000304039.11891.29. Epub 2008 Apr 23.

PMID:
18434642
[PubMed - indexed for MEDLINE]
15.

LRRK2 in Parkinson's disease: genetic and clinical studies from patients.

Kumari U, Tan EK.

FEBS J. 2009 Nov;276(22):6455-63. doi: 10.1111/j.1742-4658.2009.07344.x. Epub 2009 Oct 5. Review.

PMID:
19804413
[PubMed - indexed for MEDLINE]
16.

Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.

Lesage S, Patin E, Condroyer C, Leutenegger AL, Lohmann E, Giladi N, Bar-Shira A, Belarbi S, Hecham N, Pollak P, Ouvrard-Hernandez AM, Bardien S, Carr J, Benhassine T, Tomiyama H, Pirkevi C, Hamadouche T, Cazeneuve C, Basak AN, Hattori N, Dürr A, Tazir M, Orr-Urtreger A, Quintana-Murci L, Brice A; French Parkinson's Disease Genetics Study Group.

Hum Mol Genet. 2010 May 15;19(10):1998-2004. doi: 10.1093/hmg/ddq081. Epub 2010 Mar 2.

PMID:
20197411
[PubMed - indexed for MEDLINE]
Free Article
17.

Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects.

Change N, Mercier G, Lucotte G.

Genet Test. 2008 Sep;12(3):333-9. doi: 10.1089/gte.2007.0098.

PMID:
18666856
[PubMed - indexed for MEDLINE]
18.

Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.

Marongiu R, Ghezzi D, Ialongo T, Soleti F, Elia A, Cavone S, Albanese A, Altavista MC, Barone P, Brusa L, Cortelli P, Petrozzi L, Scaglione C, Stanzione P, Tinazzi M, Zeviani M, Dallapiccola B, Bentivoglio AR, Valente EM, Garavaglia B; Italian PD Study Group.

Mov Disord. 2006 Aug;21(8):1232-5.

PMID:
16622859
[PubMed - indexed for MEDLINE]
19.

A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.

Illarioshkin SN, Shadrina MI, Slominsky PA, Bespalova EV, Zagorovskaya TB, Bagyeva GKh, Markova ED, Limborska SA, Ivanova-Smolenskaya IA.

Eur J Neurol. 2007 Apr;14(4):413-7.

PMID:
17388990
[PubMed - indexed for MEDLINE]
20.

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.

Correia Guedes L, Ferreira JJ, Rosa MM, Coelho M, Bonifati V, Sampaio C.

Parkinsonism Relat Disord. 2010 May;16(4):237-42. doi: 10.1016/j.parkreldis.2009.11.004. Epub 2009 Nov 30. Review.

PMID:
19945904
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk